Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$27.08 USD
0.00 (0.00%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $27.09 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$27.08 USD
0.00 (0.00%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $27.09 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Zacks News
Philips (PHG) Aids Clinicians With New Monitoring Solution
by Zacks Equity Research
Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their clinical confidence.
The Zacks Analyst Blog Highlights Abbott Laboratories, Koninklijke Philips and Smith & Nephew
by Zacks Equity Research
Abbott Laboratories, Koninklijke Philips and Smith & Nephew are included in this Analyst Blog.
Why Royal Philips (PHG) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Medical Product Stocks With Solid Dividend Yield: ABT & Others
by Indrajit Bandyopadhyay
Here we pick three stocks, Abbott Laboratories (ABT), Koninklijke Philips (PHG) and Smith & Nephew SNATS (SNN) from the Medical - Products industry, with a solid five-year dividend growth history.
3 Value Medical Stocks to Buy for Safety Amid Market Volatility
by Indrajit Bandyopadhyay
We have narrowed our search to three value stocks from the Medical sector. These are PHG, RDNT and BVS.
Prestige Consumer (PBH) Stock Rallies 20% in a Year: Here's Why
by Zacks Equity Research
Prestige Consumer (PBH) benefits from a robust healthcare brand portfolio and solid demand.
Philips (PHG) Expands Mobile C-arm Portfolio With Zenition 30
by Zacks Equity Research
Philips (PHG) expands its mobile C-arm lineup with Zenition 30, which provides surgeons with more control and customization.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should Value Investors Buy Koninklijke Philips (PHG) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Koninklijke Philips (PHG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Royal Philips (PHG) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Eagle Pharmaceuticals (EGRX) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
All You Need to Know About Philips (PHG) Rating Upgrade to Strong Buy
by Zacks Equity Research
Philips (PHG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Income Stocks to Buy for August 10th
by Zacks Equity Research
TCPC, PHG and CBAN made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 10, 2023.
Should Value Investors Buy Koninklijke Philips (PHG) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Philips (PHG) Q2 Earnings Beat Estimates, Revenue Rise Y/Y
by Zacks Equity Research
Philips' (PHG) second-quarter results benefit from robust performances by the Diagnosis & Treatment and the Connected Care businesses.
Are Investors Undervaluing Koninklijke Philips (PHG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Koninklijke Philips (PHG) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is NuVasive (NUVA) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Philips' (PHG) Q1 Earnings Jump Y/Y on Strong Top-Line Growth
by Zacks Equity Research
Philips' (PHG) first-quarter results benefit from robust performances by the Diagnosis & Treatment and the Connected Care businesses.
Philips (PHG) Drives Healthcare Prospects With Enhanced Dataset
by Zacks Equity Research
Philips (PHG) announces its expansion with MIT IMES, which will help researchers and educators access a new critical care dataset.
Oracle (ORCL) and Zoom Partner to Expand Access to Virtual Care
by Zacks Equity Research
Oracle (ORCL) and Zoom enter a partnership to connect patients and their records with doctors seamlessly.
Philips (PHG) Inks 7-Year Partnership With Northwell Health
by Zacks Equity Research
Philips (PHG) announces that it has entered into a seven-year agreement with Northwell Health, one of the largest healthcare providers in the state of New York.
Philips (PHG) Drives Health Care Prospects With New Solutions
by Zacks Equity Research
Philips (PHG) announces Philips Virtual Care Management solutions, which provide a comprehensive approach to telehealth for patients, providers and payers.
AtriCure (ATRC) Moves 7.5% Higher: Will This Strength Last?
by Zacks Equity Research
AtriCure (ATRC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.